What Epistemix does

Epistemix is a Pittsburgh-based private software company founded in 2018 that builds agent-based modeling (ABM) simulation tools for enterprise and public-sector decision-making. Its flagship product, Populus, overlays user data onto statistically representative 1:1 synthetic populations to enable what-if scenario modeling across health, economic, social, and environmental outcomes. The underlying technology is the proprietary FRED (Framework for Reconstructing Epidemiological Dynamics) modeling language, developed through versions 11.0 to 13.0, with a Python client (Epx) for programmatic access and open-source availability on GitHub.

The company targets Fortune 500 executives, healthcare organizations (self-funded employers, health systems, payers), consumer insights teams, and public health agencies through a direct enterprise sales motion. In November 2025, Epistemix expanded into healthcare cost forecasting through a partnership with Gigasheet, integrating real-world provider pricing data from Machine-Readable Files into its synthetic population models. Pricing is not publicly disclosed but appears to be quote-based enterprise contracting.

The business model is subscription/SaaS-based, with $2.3M in ARR reported as of 2025. The company has raised approximately $14M+ across multiple rounds from 2021 to 2024, including a $7M round in mid-2024, with investors including Sky Ventures Group, Dangerous Ventures, New Mexico Vintage Fund, and Singularity Capital. CEO John Cordier and co-founder John Grefenstette lead the company, with Todd Cullen serving as Chief Product Officer. Headcount is reported at 11–50 employees.

Name

Epistemix

Legal name

Epistemix, Inc.

Website

https://epistemix.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Epistemix builds Populus, a synthetic population modeling platform that lets enterprises, healthcare organizations, and public agencies simulate how strategies and interventions will impact realistic demographic populations before real-world deployment.

Ownership category

akta.pro rank

Product category

Population Simulation Software

NAICS

Software Publishers (5132), Marketing Research and Public Opinion Polling (541910), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Modeling, Forecasting & Risk Assessment for Outbreaks (HLAJABAM)

akta.pro secondary industries

Digital Epidemiology & Event-Based Surveillance (media/mobility) (HLAJABAJ), Population Health Surveillance & Epidemiologic Analytics (HLAJAJAB)

Keywords

• Agent-based modeling
• Synthetic population simulation
• Scenario planning software
• Population health forecasting
• Decision intelligence platform

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. SaaS Subscription: Epistemix operates as a SaaS provider offering simulation and synthetic population modeling services on a subscription basis. The company reported $2.3M ARR in 2025, indicating a subscription-based recurring revenue model.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Epistemix provides the Populus synthetic population modeling platform, which enables organizations to run agent-based simulations on statistically representative 1:1 synthetic populations for what-if scenario planning, consumer insights, forecasting, and intervention testing across health, economic, social, and environmental outcomes. The platform is powered by the proprietary FRED agent-based modeling language and is offered primarily through enterprise SaaS subscriptions to Fortune 500 companies, healthcare organizations, and public health agencies.

Product overview

Epistemix is a population simulation and decision-support platform built around its Populus product, which uses proprietary synthetic population models for testing strategies related to health, economic, social, and environmental outcomes. The technology stack includes the FRED (Framework for Reconstructing Epidemiological Dynamics) agent-based modeling language as the simulation engine, the Epx Python package for programmatic access, and a comprehensive documentation portal. Users can leverage large population models for consumer insights, forecasting, and scenario planning through what-if scenario simulation.

Differentiator

Problem solved

Functional benefit

Brands

• Populus: Synthetic population modeling platform that enables organizations to test strategies on a population that looks and behaves like their target audience.

Products and services

• Populus

Quantifiable outcome

• Organizations can identify small changes that generate big improvements in outcomes through simulation testing

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature4 records

Partnerships

One partnership is on record.

• GigasheetcoreTechnology or Integration · 19 November 2025Epistemix partnered with Gigasheet to integrate real-world provider pricing data (Machine-Readable Files) into synthetic population models. This collaboration revolutionizes healthcare cost forecasting by combining Gigasheet's healthcare price transparency data processing with Epistemix's Populus synthetic population platform. The partnership establishes an intelligent data pipeline that delivers curated datasets from Gigasheet into the Epistemix environment, enabling reliable supply, demand, and pricing outlooks for healthcare organizations. The CEO of Gigasheet noted: 'Gigasheet provides the real-world ground truth of today where Epistemix provides a predictive look into the possibilities of tomorrow.'

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• SAS Institute: SAS offers a broad analytics and simulation suite (including SAS Simulation Studio) used by large enterprises for forecasting and scenario analysis. SAS is a broad incumbent that competes with Epistemix in healthcare, public sector, and Fortune 500 accounts, though it is not focused on synthetic population ABM.
• Palantir Technologies: Palantir's Foundry and Gotham platforms offer large-scale decision-support analytics with what-if modeling for government and Fortune 500 buyers. Palantir is a broad incumbent that overlaps with Epistemix's strategic planning and healthcare cost scenarios use cases but operates at vastly greater scale and breadth.

Direct peers

• AnyLogic: AnyLogic is an established simulation platform offering agent-based, discrete event, and system dynamics modeling — directly comparable to Epistemix's Populus ABM simulation engine. Both sell to enterprise and government buyers for what-if scenario modeling across operational and policy decisions.
• BlueDot: BlueDot is an epidemiology intelligence company that combines disease-surveillance data with modeling to forecast outbreak spread — directly comparable to Epistemix's FRED-based epidemiological simulations. Both target public health agencies and healthcare organizations for infectious-disease decision support.
• Simul8: Simul8 is a discrete event simulation platform used by enterprises to model processes and test scenarios before implementation — directly comparable to Epistemix's what-if scenario planning use case for Fortune 500 customers. Both deliver visual simulation environments for operational decision-making.

Emerging players

• Civis Analytics: Civis Analytics provides a data science platform for organizations to model audience behavior, run experiments, and forecast outcomes — overlapping with Epistemix's Consumer Insights and Fortune 500 strategic-planning segments. Both sell to enterprises seeking statistically rigorous behavioral modeling.
• Tonic.ai: Tonic.ai provides synthetic data generation for software development, testing, and analytics use cases — an adjacent capability to Epistemix's synthetic populations. Both companies monetize on the value of synthetic data as a privacy-preserving substitute for real-world datasets, and they increasingly compete for enterprise data modernization budgets.
• FlexSim: FlexSim is a 3D simulation software platform used primarily for manufacturing, logistics, and process optimization. While FlexSim is more 3D/manufacturing-focused, it overlaps with Epistemix in selling simulation software to enterprises for testing scenarios before real-world implementation.
• Gurobi Optimization: Gurobi is a mathematical optimization engine used by enterprises to model and solve complex decision problems. While Gurobi is more focused on optimization than ABM, it competes for the same enterprise decision-support budget and increasingly bundles scenario-modeling capabilities relevant to Epistemix's buyer base.

Others

• Komodo Health: Komodo Health is a healthcare data and analytics platform that provides real-world patient insights to life sciences, payers, and providers. It is comparable to Epistemix's healthcare cost-forecasting vertical as an ecosystem participant in the same buyer conversations, though its core offering is patient-level analytics rather than synthetic-population simulation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/epistemix
• GitHubgithub.com/Epistemix-Inc
• LinkedInlinkedin.com/company/epistemix

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epistemix